BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18219169)

  • 1. Association between blood pressure variability and inflammatory marker in hypertensive patients.
    Kim KI; Lee JH; Chang HJ; Cho YS; Youn TJ; Chung WY; Chae IH; Choi DJ; Park KU; Kim CH
    Circ J; 2008 Feb; 72(2):293-8. PubMed ID: 18219169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers and blood pressure: sex differences and the effect of fat mass in the CoLaus Study.
    Pruijm M; Vollenweider P; Mooser V; Paccaud F; Preisig M; Waeber G; Marques-Vidal P; Burnier M; Bochud M
    J Hum Hypertens; 2013 Mar; 27(3):169-75. PubMed ID: 22495106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults.
    Abramson JL; Lewis C; Murrah NV; Anderson GT; Vaccarino V
    Am J Cardiol; 2006 Sep; 98(5):649-52. PubMed ID: 16923454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
    Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
    J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension.
    Bautista LE; Vera LM; Arenas IA; Gamarra G
    J Hum Hypertens; 2005 Feb; 19(2):149-54. PubMed ID: 15361891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced blood pressure variability in a high cardiovascular risk group of African Americans: FIT4Life Study.
    Veerabhadrappa P; Diaz KM; Feairheller DL; Sturgeon KM; Williamson S; Crabbe DL; Kashem A; Ahrensfield D; Brown MD
    J Am Soc Hypertens; 2010; 4(4):187-95. PubMed ID: 20885987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining chronic inflammatory markers on blood pressure measures in the presence of vitamin D insufficiency among indigenous cree adults: results from the cross-sectional Multi-Community Environment-and-Health Study in
    Zuk AM; Liberda EN; Tsuji LJS
    BMJ Open; 2021 Jan; 11(1):e043166. PubMed ID: 33504558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure.
    Erdogan D; Icli A; Aksoy F; Akcay S; Ozaydin M; Ersoy I; Varol E; Dogan A
    Chronobiol Int; 2013 Oct; 30(8):973-80. PubMed ID: 23834704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma SCF/c-kit Levels in Patients with Dipper and Non-Dipper Hypertension.
    Zhong HL; Xu CL; Chen GS; Chen XM
    Chin Med Sci J; 2017 Dec; 32(4):232-238. PubMed ID: 29301598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals.
    Erden M; Kocaman SA; Poyraz F; Topal S; Sahinarslan A; Boyacı B; Cengel A; Yalçın MR
    Turk Kardiyol Dern Ars; 2011 Oct; 39(7):531-9. PubMed ID: 21983762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers.
    Barbaro NR; Fontana V; Modolo R; De Faria AP; Sabbatini AR; Fonseca FH; Anhê GF; Moreno H
    Blood Press; 2015 Feb; 24(1):7-13. PubMed ID: 25061978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
    Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I
    Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of tumor necrosis factor alpha and interleukin 6 with hypertensive renal damage.
    Yu X; Yang Z; Yu M
    Ren Fail; 2010 May; 32(4):475-9. PubMed ID: 20446787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension.
    Fang C; Lei J; Zhou SX; Zhang YL; Yuan GY; Wang JF
    Chin Med J (Engl); 2013 Feb; 126(4):646-9. PubMed ID: 23422182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The activity of nonspecific inflammation in hypertensive patients].
    Oshchepkova EV; Dmitriev VA; Titiov VN; Rogoza AN; Masenko VP
    Ter Arkh; 2007; 79(12):18-25. PubMed ID: 18220025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
    Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
    Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension.
    Roselló-Lletí E; de Burgos FG; Morillas P; Cortés R; Martínez-Dolz L; Almenar L; Grigorian L; Orosa P; Portolés M; Bertomeu V; Rivera M
    Am J Hypertens; 2012 Feb; 25(2):236-42. PubMed ID: 22052073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine is a determinant of tissue necrosis factor-alpha in hypertensive patients.
    Bogdanski P; Pupek-Musialik D; Dytfeld J; Lacinski M; Jablecka A; Jakubowski H
    Biomed Pharmacother; 2008; 62(6):360-5. PubMed ID: 18093792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.